Peregrine Pharmaceuticals shares owned by Rice Hall James & Associates
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Rice Hall James & Associates
from 13F filings
Historical chart of Rice Hall James & Associates investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Rice Hall James & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Rice Hall James & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $3.0M | 247k | 12.35 |
| 2024-09-30 | $6.4M | 565k | 11.38 |
| 2024-06-30 | $4.1M | 570k | 7.14 |
| 2024-03-31 | $2.6M | 391k | 6.70 |
| 2023-12-31 | $2.6M | 407k | 6.50 |
| 2023-09-30 | $2.4M | 252k | 9.44 |
| 2023-06-30 | $3.5M | 253k | 13.97 |
More positions owned by Rice Hall James & Associates
View all positions for Rice Hall James & Associates